we investigated the clinical pharmacokinetics of azidothymidine ( n3tdr ) as part of a phase i/ii trial in the treatment of acquired immunodeficiency syndrome and related diseases .
C0043474
azidothymidine
C0001175
acquired immunodeficiency syndrome